119 related articles for article (PubMed ID: 1710957)
1. A sensitive enzyme immunoassay for the quantitation of human C5a/C5a(desArg) anaphylatoxin using a monoclonal antibody with specificity for a neoepitope.
Oppermann M; Schulze M; Götze O
Complement Inflamm; 1991; 8(1):13-24. PubMed ID: 1710957
[TBL] [Abstract][Full Text] [Related]
2. Quantification of C5a/C5a(desArg) in bovine plasma, serum and milk.
Rainard P; Sarradin P; Paape MJ; Poutrel B
Vet Res; 1998; 29(1):73-88. PubMed ID: 9559522
[TBL] [Abstract][Full Text] [Related]
3. Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma.
Bergh K; Iversen OJ
J Immunol Methods; 1992 Jul; 152(1):79-87. PubMed ID: 1379278
[TBL] [Abstract][Full Text] [Related]
4. A sensitive ELISA for the quantitation of human C5a in blood plasma using a monoclonal antibody.
Schulze M; Götze O
Complement; 1986; 3(1):25-39. PubMed ID: 3743034
[TBL] [Abstract][Full Text] [Related]
5. Decreased survival of human breast cancer cells expressing HER2/neu on in vitro incubation with an anti-HER2/neu antibody fused to C5a or C5a desArg.
Fuenmayor J; Perez-Vazquez K; Perez-Witzke D; Penichet ML; Montano RF
Mol Cancer Ther; 2010 Aug; 9(8):2175-85. PubMed ID: 20682652
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of the anaphylatoxin C3a in the presence of C3 by a novel sandwich ELISA using monoclonal antibody to a C3a neoepitope.
Zilow G; Naser W; Rutz R; Burger R
J Immunol Methods; 1989 Jul; 121(2):261-8. PubMed ID: 2503562
[TBL] [Abstract][Full Text] [Related]
7. Surprisingly high levels of anaphylatoxin C5a des Arg are extractable from psoriatic scales.
Bergh K; Iversen OJ; Lysvand H
Arch Dermatol Res; 1993; 285(3):131-4. PubMed ID: 8503693
[TBL] [Abstract][Full Text] [Related]
8. A specific enzyme-linked immunosorbent assay (ELISA) for the determination of human C5a antigen.
Kunkel SL; Manderino GL; Marasco W; Kaercher K; Hirata AA; Ward PA
J Immunol Methods; 1983 Sep; 62(3):305-14. PubMed ID: 6193199
[TBL] [Abstract][Full Text] [Related]
9. Eculizumab-C5 complexes express a C5a neoepitope in vivo: Consequences for interpretation of patient complement analyses.
Nilsson PH; Thomas AM; Bergseth G; Gustavsen A; Volokhina EB; van den Heuvel LP; Barratt-Due A; Mollnes TE
Mol Immunol; 2017 Sep; 89():111-114. PubMed ID: 28610663
[TBL] [Abstract][Full Text] [Related]
10. Rapid quantification of C3a and C5a using a combination of chromatographic and immunoassay procedures.
Hartmann H; Lübbers B; Casaretto M; Bautsch W; Klos A; Köhl J
J Immunol Methods; 1993 Nov; 166(1):35-44. PubMed ID: 7693822
[TBL] [Abstract][Full Text] [Related]
11. Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies.
Klos A; Ihrig V; Messner M; Grabbe J; Bitter-Suermann D
J Immunol Methods; 1988 Jul; 111(2):241-52. PubMed ID: 3260926
[TBL] [Abstract][Full Text] [Related]
12. The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg).
Werfel T; Oppermann M; Butterfield JH; Begemann G; Elsner J; Götze O; Zwirner J
Scand J Immunol; 1996 Jul; 44(1):30-6. PubMed ID: 8693289
[TBL] [Abstract][Full Text] [Related]
13. C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assay.
Reis ES; Chen H; Sfyroera G; Monk PN; Köhl J; Ricklin D; Lambris JD
J Immunol; 2012 Nov; 189(10):4797-805. PubMed ID: 23041570
[TBL] [Abstract][Full Text] [Related]
14. C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection.
Kacani L; Bánki Z; Zwirner J; Schennach H; Bajtay Z; Erdei A; Stoiber H; Dierich MP
J Immunol; 2001 Mar; 166(5):3410-5. PubMed ID: 11207298
[TBL] [Abstract][Full Text] [Related]
15. Rapid and simple measurement of human C5a-des-Arg level in plasma or serum using monoclonal antibodies.
Takeda J; Kinoshita T; Takata Y; Kozono H; Tanaka E; Hong K; Inoue K
J Immunol Methods; 1987 Aug; 101(2):265-70. PubMed ID: 3611800
[TBL] [Abstract][Full Text] [Related]
16. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
Sorgenfrei J; Damerau B; Vogt W
Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
[TBL] [Abstract][Full Text] [Related]
17. Phagocytosis and killing of Staphylococcus aureus by bovine neutrophils after priming by tumor necrosis factor-alpha and the des-arginine derivative of C5a.
Rainard P; Riollet C; Poutrel B; Paape MJ
Am J Vet Res; 2000 Aug; 61(8):951-9. PubMed ID: 10951989
[TBL] [Abstract][Full Text] [Related]
18. C5 neoepitopes appearing during activation.
Inoue K
Complement Inflamm; 1989; 6(3):219-22. PubMed ID: 2472923
[TBL] [Abstract][Full Text] [Related]
19. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.
Fung M; Lu M; Fure H; Sun W; Sun C; Shi NY; Dou Y; Su J; Swanson X; Mollnes TE
Clin Exp Immunol; 2003 Aug; 133(2):160-9. PubMed ID: 12869020
[TBL] [Abstract][Full Text] [Related]
20. Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin.
Mollnes TE; Videm V; Götze O; Harboe M; Oppermann M
Ann Thorac Surg; 1991 Jul; 52(1):92-7. PubMed ID: 2069469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
